Jsmc-10259

PREVALENCE AND EFFECT OF IRON DEFICIENCY ANEMIA IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Taha Othman Mahwi  a and Blnd Ahmad Aziz b

a College of Medicine, University of Sulaimani, Kurdistan Region, Iraq. 

b General Internal Medical hospital, Sulaimani, Kurdistan Region, Iraq.

Submitted: 12/7/2019; Accepted: 27/7/2020; Published: 21/9/2020

DOI Link: https://doi.org/10.17656/jsmc.10259 

ABSTRACT

Background 

Anemia is progressively recognized as significant comorbidity in the context of chronic obstructive pulmonary disease (COPD). 

Objectives 

To determine the extent of iron deficiency anemia in both exacerbation of COPD and stable COPD.

Patients and Methods

A prospective, multicenter, cross-sectional study was conducted between April 2017 and January 2018. Two groups of patients were enrolled, group A included those patients admitted in the emergency rooms for the management of acute exacerbation of COPD and group B comprised of those patients with stable COPD visited the consultatory medical department. Inclusion criteria included those patients known cases of COPD and categorized according to the GOLD criteria. 

Results

The study included 150 patients. Group A contained 100 patients. Seventy-nine (79%) were male with a mean age and standard deviation of 66.77 years ± 12.07 years. While the other groups (group B) comprised of 50 patients, 39 (78%) were male with a mean age of 59.86 years ± 9.87 years. The inflammatory marker was significantly more positive in group A (89, 89%) compared to group B (6, 12%), P-value 0.0001. Overall, the low iron profile was found in 15 (15%) patients in group A, and in 2 (4%) patients in group B (P-value 0.0559). Both iron and non-iron deficiency anemia were more prevalent among the exacerbation group (group A).

Conclusion

Anemia is a relatively common finding among COPD patients (both IDA and non-IDA). It is more prevalent among those patients developing frequent exacerbations.  

KEYWORDS

Iron deficiency anemia; COPD; Exacerbation COPD; Chronic obstructive pulmonary disease.

References 

1. American Thoracic Society/European Respiratory Society Task Force: Standards for the diagnosis and management of patients with COPD. Version 1.2. New York: American Thoracic Society, 2004. PDF available for download at https://www.thoracic.org/copdguidelines/resources/copddoc.pdf 

2. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011. Available from: goldcopd.org. 

3. Lee SJ, Kim SW, Kong KA, Ryu YJ, Lee JH, Chang JH. Risk factors for chronic obstructive pulmonary disease among never-smokers in Korea. Int J Chron Obstruct Pulmon Dis. 2015; 10:497-506.

4. Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest. 2000; 117(5 Suppl 2):398S-401S.

5. Kendrick S. Emergency admissions: what is driving the increase? Health Serv J. 1995; 105(5451):26-8.

6. Robalo Nunes A, Tata M. The impact of anaemia and iron deficiency in chronic obstructive pulmonary disease: A clinical overview. Rev Port Pneumol (2006). 2017; 23(3):146-55.

7. GOLD Committees. Global Initiative for Obstructive Lung Disease (GOLD), Introduction, 2011, p. vii. Available on https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.7-FINAL-14Nov2018-WMS.pdf

8. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006; 28(3):523-32.

9. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005; 352(10):1011-23.

10. Chapman KR, Tashkin DP, Pye DJ. Gender bias in the diagnosis of COPD. Chest. 2001; 119(6):1691-5.

11. Zavarreh RH, Ahmatkesh M, Vakili M, Ahmadi AS, Zohal MA, Arabi M, et al. Association between Anemia and COPD in Iranian Population. IJHOSCR. 2013; 7:1-10. 

12. Hussein MA, Hashim Al-Kadhimi HM. Value of C Reactive Protein Measurements in Exacerbations of Chronic Obstructive Pulmonary Disease. Al -Nahrain College of Medicine ISSN1681-6579. 

13. Aksu F, Capan N, Aksu K, Ofluoglu R, Canbakan S, Yavuz B, et al. C-reactive protein levels are raised in stable Chronic obstructive pulmonary disease patients independent of smoking behavior and biomass exposure. J Thorac Dis. 2013; 5(4):414-21.

14. Nickol AH, Frise MC, Cheng HY, McGahey A, McFadyen BM, Harris-Wright T, et al. A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease. BMJ Open. 2015; 5(7).

15. Plesner LL, Schoos MM, Dalsgaard M, Goetze JP, Kjoller E, Vestbo J, et al. Iron Deficiency in COPD Associates with Increased Pulmonary Artery Pressure Estimated by Echocardiography. Heart Lung Circ. 2017; 26(1):101-4.

Full Text

 © The Authors, published by University of Sulaimani, College of Medicine

This work is licensed under a Creative Commons Attribution 4.0 International License.